-
1
-
-
0031585940
-
Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46:1-24.
-
(1997)
MMWR Recomm Rep
, vol.46
, pp. 1-24
-
-
-
2
-
-
0035006585
-
Pneumococcal disease in the elderly: What is preventing vaccine efficacy?
-
Rubins JB, Janoff EN. Pneumococcal disease in the elderly: what is preventing vaccine efficacy? Drugs Aging 2001; 18:305-311.
-
(2001)
Drugs Aging
, vol.18
, pp. 305-311
-
-
Rubins, J.B.1
Janoff, E.N.2
-
3
-
-
0027375327
-
Pneumococcal polysaccharide vaccine efficacy: An evaluation of current recommendations
-
Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270:1826-1831.
-
(1993)
JAMA
, vol.270
, pp. 1826-1831
-
-
Butler, J.C.1
Breiman, R.F.2
Campbell, J.F.3
Lipman, H.B.4
Broome, C.V.5
Facklam, R.R.6
-
4
-
-
0038470983
-
Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: Role of comorbid conditions and race
-
Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Intern Med 2003; 138:960-968.
-
(2003)
Ann Intern Med
, vol.138
, pp. 960-968
-
-
Sisk, J.E.1
Whang, W.2
Butler, J.C.3
Sneller, V.P.4
Whitney, C.G.5
-
5
-
-
42549120339
-
-
Available at:, Accessed September 30, 2007
-
Centers for Disease Control and Prevention - National Center for Health Statistics. NCHS-NHIS data from the January-September 2005 National Health Interview Survey. 2006. Available at: http://www.cdc.gov/nchs/about/major/nhis/ released200603.htm#4. Accessed September 30, 2007.
-
(2006)
NCHS-NHIS data from the January-September 2005 National Health Interview Survey
-
-
-
6
-
-
42549093715
-
-
US Department of Health and Human Services. Healthy People 2010 1: Understanding and Improving Health and 2: Objectives for Improving Health. 2nd ed. Washington, DC: US Government Printing Office; 2000.
-
US Department of Health and Human Services. Healthy People 2010 Vol. 1: Understanding and Improving Health and Vol. 2: Objectives for Improving Health. 2nd ed. Washington, DC: US Government Printing Office; 2000.
-
-
-
-
7
-
-
0013225804
-
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
-
Moore RA, Wiffen PJ, Lipsky BA. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Family Practice 2000; 1:1.
-
(2000)
BMC Family Practice
, vol.1
, pp. 1
-
-
Moore, R.A.1
Wiffen, P.J.2
Lipsky, B.A.3
-
8
-
-
33645773652
-
Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia
-
Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006; 42:1093-1101.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 1093-1101
-
-
Fisman, D.N.1
Abrutyn, E.2
Spaude, K.A.3
Kim, A.4
Kirchner, C.5
Daley, J.6
-
9
-
-
0020160640
-
Hospital-based pneumococcal immunization: The epidemiologic rationale and its implementation
-
Fedson DS. Hospital-based pneumococcal immunization: the epidemiologic rationale and its implementation. Infect Control 1982; 3:303-308.
-
(1982)
Infect Control
, vol.3
, pp. 303-308
-
-
Fedson, D.S.1
-
10
-
-
0026042704
-
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
-
Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325:1453-1460.
-
(1991)
N Engl J Med
, vol.325
, pp. 1453-1460
-
-
Shapiro, E.D.1
Berg, A.T.2
Austrian, R.3
-
11
-
-
2442677289
-
Advisory Committee on Immunization Practices. Use of standing orders programs to increase adult vaccination rates
-
McKibben LJ, Stange PV, Sneller VP, Strikas RA, Rodewald LE, Advisory Committee on Immunization Practices. Use of standing orders programs to increase adult vaccination rates. MMWR Recomm Rep 2000; 49:15-16.
-
(2000)
MMWR Recomm Rep
, vol.49
, pp. 15-16
-
-
McKibben, L.J.1
Stange, P.V.2
Sneller, V.P.3
Strikas, R.A.4
Rodewald, L.E.5
-
12
-
-
8544283806
-
Inpatient computer-based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates
-
Dexter PR, Perkins SM, Maharry KS, Jones K, McDonald CJ. Inpatient computer-based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates. JAMA 2004; 292:2366-2371.
-
(2004)
JAMA
, vol.292
, pp. 2366-2371
-
-
Dexter, P.R.1
Perkins, S.M.2
Maharry, K.S.3
Jones, K.4
McDonald, C.J.5
-
13
-
-
14844355721
-
Characteristics of long-term care facilities with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states
-
Shefer A, McKibben L, Bardenheier B, Bratzler D, Roberts H. Characteristics of long-term care facilities with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states. J Am Med Dir Assoc 2005; 6:97-104.
-
(2005)
J Am Med Dir Assoc
, vol.6
, pp. 97-104
-
-
Shefer, A.1
McKibben, L.2
Bardenheier, B.3
Bratzler, D.4
Roberts, H.5
-
14
-
-
33846813625
-
Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients
-
Bakare M, Shrivastava R, Jeevanantham V, Navaneethan SD. Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients. South Med J 2007; 100:140-144.
-
(2007)
South Med J
, vol.100
, pp. 140-144
-
-
Bakare, M.1
Shrivastava, R.2
Jeevanantham, V.3
Navaneethan, S.D.4
-
15
-
-
33846228479
-
Cost-effectiveness of hospital vaccination programs in North Carolina
-
Honeycutt AA, Coleman MS, Anderson WL, Wirth KE. Cost-effectiveness of hospital vaccination programs in North Carolina. Vaccine 2007; 25:1484-1496.
-
(2007)
Vaccine
, vol.25
, pp. 1484-1496
-
-
Honeycutt, A.A.1
Coleman, M.S.2
Anderson, W.L.3
Wirth, K.E.4
-
16
-
-
85136427856
-
-
Sisk J, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people [published correction appears in JAMA 2000; 283:341]. JAMA 1997; 278:1333-1339.
-
Sisk J, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people [published correction appears in JAMA 2000; 283:341]. JAMA 1997; 278:1333-1339.
-
-
-
-
17
-
-
0037009882
-
Medicare and Medicaid programs; conditions of participation: Immunization standards for hospitals, long-term care facilities, and home health agencies: final rule with comment period
-
Centers for Medicare and Medicaid Series H
-
Centers for Medicare and Medicaid Series H. Medicare and Medicaid programs; conditions of participation: immunization standards for hospitals, long-term care facilities, and home health agencies: final rule with comment period. Fed Reg 2002; 67:61808-61814.
-
(2002)
Fed Reg
, vol.67
, pp. 61808-61814
-
-
-
18
-
-
0042706430
-
Increasing pneumococcal vaccination rates among hospitalized patients
-
Nowalk MP, Middleton DB, Zimmerman RK, Hess MM, Skledar SJ, Jacobs MA. Increasing pneumococcal vaccination rates among hospitalized patients. Infect Control Hosp Epidemiol 2003; 24:526-531.
-
(2003)
Infect Control Hosp Epidemiol
, vol.24
, pp. 526-531
-
-
Nowalk, M.P.1
Middleton, D.B.2
Zimmerman, R.K.3
Hess, M.M.4
Skledar, S.J.5
Jacobs, M.A.6
-
19
-
-
0142089731
-
Designing a hospital-based pneumococcal vaccination program
-
Skledar SJ, Hess MM, Ervin KA, et al. Designing a hospital-based pneumococcal vaccination program. Am J Health Syst Pharm 2003; 60:1471-1476.
-
(2003)
Am J Health Syst Pharm
, vol.60
, pp. 1471-1476
-
-
Skledar, S.J.1
Hess, M.M.2
Ervin, K.A.3
-
20
-
-
42549128864
-
-
Centers for Disease Control and Prevention. Self-reported pneumococcal vaccination coverage trends 1989-2005 among adults by age group, risk group, race/ethnicity, health-care worker status, and pregnancy status, United States, National Health Interview Survey (NHIS). Available at: http://www.cdc.gov/flu/ professionals/vaccination/pdf/pneumococcal-vaccinetrend.pdf. Accessed September 30, 2007.
-
Centers for Disease Control and Prevention. Self-reported pneumococcal vaccination coverage trends 1989-2005 among adults by age group, risk group, race/ethnicity, health-care worker status, and pregnancy status, United States, National Health Interview Survey (NHIS). Available at: http://www.cdc.gov/flu/ professionals/vaccination/pdf/pneumococcal-vaccinetrend.pdf. Accessed September 30, 2007.
-
-
-
-
21
-
-
0037163462
-
Pneumococcal vaccination: Analysis of opportunities in an inner-city hospital
-
Husain S, Slobodkin D, Weinstein RA. Pneumococcal vaccination: analysis of opportunities in an inner-city hospital. Arch Intern Med 2002; 162:1961-1965.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1961-1965
-
-
Husain, S.1
Slobodkin, D.2
Weinstein, R.A.3
-
22
-
-
33749351792
-
Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years - United States, 2004-2005
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years - United States, 2004-2005. MMWR Morb Mortal Wkly Rep 2006; 55:1065-1068.
-
(2006)
MMWR Morb Mortal Wkly Rep
, vol.55
, pp. 1065-1068
-
-
-
23
-
-
0006873196
-
-
Available at:, Accessed September 30, 2007
-
Agency for Healthcare Research and Quality. Healthcare Cost & Utilization Project (HCUP). 2003. Available at: http://www.ahrq.gov/data/hcup/. Accessed September 30, 2007.
-
(2003)
Healthcare Cost & Utilization Project (HCUP)
-
-
-
24
-
-
27244440305
-
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
-
Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294:2043-2051.
-
(2005)
JAMA
, vol.294
, pp. 2043-2051
-
-
Lexau, C.A.1
Lynfield, R.2
Danila, R.3
-
25
-
-
0035825293
-
Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines
-
Weaver M, Krieger J, Castorina J, Walls M, Ciske S. Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines. Arch Intern Med 2001; 161:111-120.
-
(2001)
Arch Intern Med
, vol.161
, pp. 111-120
-
-
Weaver, M.1
Krieger, J.2
Castorina, J.3
Walls, M.4
Ciske, S.5
-
26
-
-
0035804857
-
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era
-
Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285:1729-1735.
-
(2001)
JAMA
, vol.285
, pp. 1729-1735
-
-
Robinson, K.A.1
Baughman, W.2
Rothrock, G.3
-
31
-
-
0038470983
-
Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: Role of comorbid conditions and race
-
Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Intern Med 2003; 138:960-968.
-
(2003)
Ann Intern Med
, vol.138
, pp. 960-968
-
-
Sisk, J.E.1
Whang, W.2
Butler, J.C.3
Sneller, V.P.4
Whitney, C.G.5
-
32
-
-
0033585453
-
Safety of revaccination with pneumococcal polysaccharide vaccine
-
Jackson LA, Benson P, Sneller VP, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 1999; 281:243-248.
-
(1999)
JAMA
, vol.281
, pp. 243-248
-
-
Jackson, L.A.1
Benson, P.2
Sneller, V.P.3
-
33
-
-
0026575912
-
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations
-
Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146:473-481.
-
(1992)
CMAJ
, vol.146
, pp. 473-481
-
-
Laupacis, A.1
Feeny, D.2
Detsky, A.S.3
Tugwell, P.X.4
-
34
-
-
0028046941
-
Influenza vaccination programs for elderly persons: Cost-effectiveness in a health maintenance organization
-
Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121:947-952.
-
(1994)
Ann Intern Med
, vol.121
, pp. 947-952
-
-
Mullooly, J.P.1
Bennett, M.D.2
Hornbrook, M.C.3
-
35
-
-
0028048820
-
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
-
Nichol KL, Margolis KL, Wuorenma J, Von Sternberg TL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331:778-784.
-
(1994)
N Engl J Med
, vol.331
, pp. 778-784
-
-
Nichol, K.L.1
Margolis, K.L.2
Wuorenma, J.3
Von Sternberg, T.L.4
-
36
-
-
34248230801
-
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
-
Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007; 44:1280-1288.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 1280-1288
-
-
Rothberg, M.B.1
Virapongse, A.2
Smith, K.J.3
-
37
-
-
33749048487
-
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
-
Hornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med 2006; 145:317-325.
-
(2006)
Ann Intern Med
, vol.145
, pp. 317-325
-
-
Hornberger, J.1
Robertus, K.2
-
38
-
-
16544388321
-
Adult immunization programs in nontraditional settings: Quality standards and guidance for program evaluation
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Morbid Mortal Wkly Rep 2000; 49(RR-01):1-13.
-
(2000)
MMWR Morbid Mortal Wkly Rep
, vol.49
, Issue.RR-01
, pp. 1-13
-
-
-
39
-
-
27944475568
-
Overcoming barriers to establishing an inpatient vaccination program for pneumococcus using standing orders
-
Middleton DB, Fox DE, Nowalk MP, et al. Overcoming barriers to establishing an inpatient vaccination program for pneumococcus using standing orders. Infect Control Hosp Epidemiol 2005; 26:874-881.
-
(2005)
Infect Control Hosp Epidemiol
, vol.26
, pp. 874-881
-
-
Middleton, D.B.1
Fox, D.E.2
Nowalk, M.P.3
-
40
-
-
26444552099
-
Policies to increase influenza and pneumococcal immunizations in chronically ill and institutionalized settings
-
Goldstein AO, Kincade JE, Resnick JE, Gamble G, Bearman RS. Policies to increase influenza and pneumococcal immunizations in chronically ill and institutionalized settings. Am J Infect Control 2005; 33:463-468.
-
(2005)
Am J Infect Control
, vol.33
, pp. 463-468
-
-
Goldstein, A.O.1
Kincade, J.E.2
Resnick, J.E.3
Gamble, G.4
Bearman, R.S.5
-
41
-
-
34249082853
-
Designing and implementing a hospital-based vaccine standing orders program
-
Sokos D, Skledar S, Ervin K, et al. Designing and implementing a hospital-based vaccine standing orders program. Am J Health Syst Pharm 2007; 64:1096-1102.
-
(2007)
Am J Health Syst Pharm
, vol.64
, pp. 1096-1102
-
-
Sokos, D.1
Skledar, S.2
Ervin, K.3
-
42
-
-
42549100054
-
-
Lindley M, Shefer A, and Shaw F. Assessing state immunization requirements for healthcare workers and patients. In: Program and abstracts of the 40th National Immunization Conference; 2006; Atlanta, GA.
-
Lindley M, Shefer A, and Shaw F. Assessing state immunization requirements for healthcare workers and patients. In: Program and abstracts of the 40th National Immunization Conference; 2006; Atlanta, GA.
-
-
-
-
43
-
-
37349009553
-
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine PCV7 serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004
-
Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine PCV7 serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196:1346-1354.
-
(2007)
J Infect Dis
, vol.196
, pp. 1346-1354
-
-
Hicks, L.A.1
Harrison, L.H.2
Flannery, B.3
-
44
-
-
0022896971
-
Efficacy of pneumococcal vaccine in high-risk patients: Results of a Veterans Administration Cooperative Study
-
Simberkoff MS, Cross AP, Al-Ibrahim M, et al. Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 315:1318-1327.
-
(1986)
N Engl J Med
, vol.315
, pp. 1318-1327
-
-
Simberkoff, M.S.1
Cross, A.P.2
Al-Ibrahim, M.3
-
45
-
-
0027887335
-
Pneumococcal vaccination in the prevention of community-acquired pneumonia: An optimistic view of cost-effectiveness
-
Fedson DS. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness. Semin Respir Infect 1993; 8:285-293.
-
(1993)
Semin Respir Infect
, vol.8
, pp. 285-293
-
-
Fedson, D.S.1
-
46
-
-
0022645087
-
Cost effectiveness of vaccination against pneumococcal pneumonia: An update
-
Sisk JE, Riegelman RK. Cost effectiveness of vaccination against pneumococcal pneumonia: an update. Ann Intern Med 1986; 104:79-86.
-
(1986)
Ann Intern Med
, vol.104
, pp. 79-86
-
-
Sisk, J.E.1
Riegelman, R.K.2
-
47
-
-
0025695549
-
Pneumococcal vaccine: Efficacy and associated cost savings
-
Gable CB, Holzer SS, Engelhart L, et al. Pneumococcal vaccine: efficacy and associated cost savings. JAMA 1990; 264:2910-2915.
-
(1990)
JAMA
, vol.264
, pp. 2910-2915
-
-
Gable, C.B.1
Holzer, S.S.2
Engelhart, L.3
-
48
-
-
0019379183
-
A cost-benefit analysis of immunization for pneumococcal pneumonia
-
Patrick KM, Woolley FR. A cost-benefit analysis of immunization for pneumococcal pneumonia. JAMA 1981; 245:473-477.
-
(1981)
JAMA
, vol.245
, pp. 473-477
-
-
Patrick, K.M.1
Woolley, F.R.2
-
50
-
-
3242885700
-
Economic aspects of pneumococcal pneumonia: A review of the literature
-
DeGraeve D, Beutels P. Economic aspects of pneumococcal pneumonia: a review of the literature. Pharmacoeconomics 2004; 22:719-740.
-
(2004)
Pharmacoeconomics
, vol.22
, pp. 719-740
-
-
DeGraeve, D.1
Beutels, P.2
-
51
-
-
0034101109
-
Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium
-
DeGraeve D, Lombaert G, Goossens H. Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium. Pharmacoeconomics 2000; 17:591-601.
-
(2000)
Pharmacoeconomics
, vol.17
, pp. 591-601
-
-
DeGraeve, D.1
Lombaert, G.2
Goossens, H.3
-
52
-
-
0242600542
-
Effectiveness of pneumococcal polysaccharide vaccine in older adults
-
Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348:1747-1755.
-
(2003)
N Engl J Med
, vol.348
, pp. 1747-1755
-
-
Jackson, L.A.1
Neuzil, K.M.2
Yu, O.3
-
53
-
-
0028075609
-
Efficacy of pneumococcal vaccination in adults: A meta-analysis of randomized controlled trials
-
Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154:2666-2677.
-
(1994)
Arch Intern Med
, vol.154
, pp. 2666-2677
-
-
Fine, M.J.1
Smith, M.A.2
Carson, C.A.3
-
54
-
-
20444390513
-
Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska
-
Walker FJ, Singleton RJ, Bulkow LR, Strikas RA, Butler JC. Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska. Clin Infect Dis 2005; 40:1730-1735.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 1730-1735
-
-
Walker, F.J.1
Singleton, R.J.2
Bulkow, L.R.3
Strikas, R.A.4
Butler, J.C.5
|